ClearOne announced that a majority shareholder has provided written consent to approve the issuance of 12.5 million shares of common stock in connection with its previously disclosed merger agreement with Cortigent, Inc. The approval, which represents a change of control, also includes the adoption of a new 2026 Omnibus Incentive Plan. The actions clear a key hurdle for the completion of the merger.
Key Details
- Stockholder Approval: On August 3, 2026, First Finance, Ltd., which holds approximately 61.3% of the company's voting power, approved the stock issuance and the 2026 Omnibus Incentive Plan by written consent.
- CFO Employment Agreement: On July 31, 2026, the company entered into a new employment agreement with CFO Simon Brewer, effective upon the Cortigent merger closing. The agreement includes a $300,000 annual base salary and a stock option grant to purchase 200,000 shares.
- Warrant Cancellation: In a related move on August 4, 2026, the company entered an agreement with First Finance Ltd. to cancel outstanding warrants to purchase 437,500 shares of common stock at an exercise price of $5.00 per share.